Tal Dagan, MD
Facial Plastic Surgery · New York, NYNPI 1013997980
Payments from drug & device makers
What this record shows
This record is dominated by other: $2,746 of the $3,900 with a category attached, or 70.4%. Olympus America Inc. accounts for 70.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $2,746 and has fallen 92.0% since, to $221 in 2025.
Across 57 payments — averaging $68.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$3K
- GSK$482
- Sanofi$481
- Intersect ENT, Inc.$57
- Acclarent, Inc$26
- Inspire Medical Systems, Inc.$25
- plus $83 from 4 others
What the payments were for
- Food & beverage$1,15430%
- Other$2,74670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 1 | $2,746 |
| GSK | 29 | $482 |
| Sanofi | 18 | $481 |
| Intersect ENT, Inc. | 3 | $57 |
| Acclarent, Inc | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Medtronic | 1 | $24 |
| Stryker | 1 | $23 |
| Phadia US Inc. | 1 | $19 |
| Advanced Oxygen Therapy Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DIEGO SUCTION-IRRIGATION TUBING SET, DISPOSABLE 12'(3.66 m) LENGTH N$2,746
- MULTIDEBRIDER HANDPIECE, ANGLED DIEGO ELITE$2,746
How this compares
$3,900 in reported general payments places this provider in the 75th percentile of 48 facial plastic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $44,726 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in New York
- Joshua RosenbergNew York$61K
- Allison PontiusNew York$55K
- Lesley RabachNew York$9K
- Daniel DemeshNew York$6K
- Steven PearlmanNew York$6K
- Yael HalaasNew York$6K
- Corinne HornNew York$3K
- Grigoriy MashkevichNew York$2K
- William HeckmanNew York$2K
- Bernard PacellaNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.